Evotec (OTCMKTS:EVTCY) Stock Crosses Below 200 Day Moving Average – Should You Sell?

Evotec SE (OTCMKTS:EVTCY)’s share price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.62 and traded as low as $1.8389. Evotec shares last traded at $1.86, with a volume of 121,907 shares.

Evotec Price Performance

The firm has a market cap of $614.21 million, a P/E ratio of 4.54 and a beta of 0.98. The stock’s 50-day moving average is $2.15 and its 200-day moving average is $2.62. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53.

Evotec Company Profile

Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.

The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.